
Envista Holdings Corp
- Jurisdiction
United States - LEI
549300BX623VURJZ5269 - ISIN
US29415F1049 (NVST )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. Read full profile
Fundamentals
- Net revenue
€2.19B - Gross margin
54.1% - EBIT
€117.11M - EBIT margin
5.3% - Net income
-€951.72M - Net margin
-43.4%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Reis Mischa | SVP, Strategy & Bus. Dev. |
|
|
|
|
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
John D. Spears |
|
|
|
Sell |
Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: May 1, 2024 (Q1 2024)